Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Alimta Market Research Report 2025

Global Alimta Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-02-25

Pages: 69 Pages

Report ld: 4302187

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Alimta was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

North American market for Alimta is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Alimta is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Alimta include Eli Lilly, Abbott Healthcare, Cadila Healthcare, Eagle Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

biaoTi Report Scope

This report aims to provide a comprehensive presentation of the global market for Alimta, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alimta.

The Alimta market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alimta market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alimta manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Eli Lilly

Abbott Healthcare

Cadila Healthcare

Eagle Pharmaceuticals

Segment by Type

100mg

500mg

Segment by Application

Pleural Mesothelioma

Non-small Cell Lung Cancer

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Alimta manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Alimta in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYResearch's Strengths

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Alimta Market Overview

1.1 Product Definition

1.2 Alimta by Type

1.2.1 Global Alimta Market Value Comparison by Type (2024 VS 2031)

1.2.2 100mg

1.2.3 500mg

1.3 Alimta by Application

1.3.1 Global Alimta Market Value by Application (2024 VS 2031)

1.3.2 Pleural Mesothelioma

1.3.3 Non-small Cell Lung Cancer

1.4 Global Alimta Market Size Estimates and Forecasts

1.4.1 Global Alimta Revenue 2020-2031

1.4.2 Global Alimta Sales 2020-2031

1.4.3 Global Alimta Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Alimta Market Competition by Manufacturers

2.1 Global Alimta Sales Market Share by Manufacturers (2020-2025)

2.2 Global Alimta Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Alimta Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Alimta, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Alimta, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Alimta, Product Type & Application

2.7 Global Key Manufacturers of Alimta, Date of Enter into This Industry

2.8 Global Alimta Market Competitive Situation and Trends

2.8.1 Global Alimta Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Alimta Players Market Share by Revenue

2.8.3 Global Alimta Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Alimta Market Scenario by Region

3.1 Global Alimta Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Alimta Sales by Region: 2020-2031

3.2.1 Global Alimta Sales by Region: 2020-2025

3.2.2 Global Alimta Sales by Region: 2026-2031

3.3 Global Alimta Revenue by Region: 2020-2031

3.3.1 Global Alimta Revenue by Region: 2020-2025

3.3.2 Global Alimta Revenue by Region: 2026-2031

3.4 North America Alimta Market Facts & Figures by Country

3.4.1 North America Alimta Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Alimta Sales by Country (2020-2031)

3.4.3 North America Alimta Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Alimta Market Facts & Figures by Country

3.5.1 Europe Alimta Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Alimta Sales by Country (2020-2031)

3.5.3 Europe Alimta Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Alimta Market Facts & Figures by Region

3.6.1 Asia Pacific Alimta Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Alimta Sales by Region (2020-2031)

3.6.3 Asia Pacific Alimta Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Alimta Market Facts & Figures by Country

3.7.1 Latin America Alimta Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Alimta Sales by Country (2020-2031)

3.7.3 Latin America Alimta Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Alimta Market Facts & Figures by Country

3.8.1 Middle East and Africa Alimta Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Alimta Sales by Country (2020-2031)

3.8.3 Middle East and Africa Alimta Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Alimta Sales by Type (2020-2031)

4.1.1 Global Alimta Sales by Type (2020-2025)

4.1.2 Global Alimta Sales by Type (2026-2031)

4.1.3 Global Alimta Sales Market Share by Type (2020-2031)

4.2 Global Alimta Revenue by Type (2020-2031)

4.2.1 Global Alimta Revenue by Type (2020-2025)

4.2.2 Global Alimta Revenue by Type (2026-2031)

4.2.3 Global Alimta Revenue Market Share by Type (2020-2031)

4.3 Global Alimta Price by Type (2020-2031)

5 Segment by Application

5.1 Global Alimta Sales by Application (2020-2031)

5.1.1 Global Alimta Sales by Application (2020-2025)

5.1.2 Global Alimta Sales by Application (2026-2031)

5.1.3 Global Alimta Sales Market Share by Application (2020-2031)

5.2 Global Alimta Revenue by Application (2020-2031)

5.2.1 Global Alimta Revenue by Application (2020-2025)

5.2.2 Global Alimta Revenue by Application (2026-2031)

5.2.3 Global Alimta Revenue Market Share by Application (2020-2031)

5.3 Global Alimta Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Eli Lilly

6.1.1 Eli Lilly Company Information

6.1.2 Eli Lilly Description and Business Overview

6.1.3 Eli Lilly Alimta Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Eli Lilly Alimta Product Portfolio

6.1.5 Eli Lilly Recent Developments/Updates

6.2 Abbott Healthcare

6.2.1 Abbott Healthcare Company Information

6.2.2 Abbott Healthcare Description and Business Overview

6.2.3 Abbott Healthcare Alimta Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Abbott Healthcare Alimta Product Portfolio

6.2.5 Abbott Healthcare Recent Developments/Updates

6.3 Cadila Healthcare

6.3.1 Cadila Healthcare Company Information

6.3.2 Cadila Healthcare Description and Business Overview

6.3.3 Cadila Healthcare Alimta Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Cadila Healthcare Alimta Product Portfolio

6.3.5 Cadila Healthcare Recent Developments/Updates

6.4 Eagle Pharmaceuticals

6.4.1 Eagle Pharmaceuticals Company Information

6.4.2 Eagle Pharmaceuticals Description and Business Overview

6.4.3 Eagle Pharmaceuticals Alimta Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Eagle Pharmaceuticals Alimta Product Portfolio

6.4.5 Eagle Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Alimta Industry Chain Analysis

7.2 Alimta Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Alimta Production Mode & Process Analysis

7.4 Alimta Sales and Marketing

7.4.1 Alimta Sales Channels

7.4.2 Alimta Distributors

7.5 Alimta Customer Analysis

8 Alimta Market Dynamics

8.1 Alimta Industry Trends

8.2 Alimta Market Drivers

8.3 Alimta Market Challenges

8.4 Alimta Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

Table of Figures

List of Tables

Table 1. Global Alimta Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Alimta Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Alimta Market Competitive Situation by Manufacturers in 2024

Table 4. Global Alimta Sales (Kg) of Key Manufacturers (2020-2025)

Table 5. Global Alimta Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Alimta Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Alimta Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Alimta Average Price (USD/g) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Alimta, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Alimta, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Alimta, Product Type & Application

Table 12. Global Key Manufacturers of Alimta, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Alimta by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alimta as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Alimta Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Alimta Sales by Region (2020-2025) & (Kg)

Table 18. Global Alimta Sales Market Share by Region (2020-2025)

Table 19. Global Alimta Sales by Region (2026-2031) & (Kg)

Table 20. Global Alimta Sales Market Share by Region (2026-2031)

Table 21. Global Alimta Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Alimta Revenue Market Share by Region (2020-2025)

Table 23. Global Alimta Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Alimta Revenue Market Share by Region (2026-2031)

Table 25. North America Alimta Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Alimta Sales by Country (2020-2025) & (Kg)

Table 27. North America Alimta Sales by Country (2026-2031) & (Kg)

Table 28. North America Alimta Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Alimta Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Alimta Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Alimta Sales by Country (2020-2025) & (Kg)

Table 32. Europe Alimta Sales by Country (2026-2031) & (Kg)

Table 33. Europe Alimta Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Alimta Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Alimta Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Alimta Sales by Region (2020-2025) & (Kg)

Table 37. Asia Pacific Alimta Sales by Region (2026-2031) & (Kg)

Table 38. Asia Pacific Alimta Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Alimta Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Alimta Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Alimta Sales by Country (2020-2025) & (Kg)

Table 42. Latin America Alimta Sales by Country (2026-2031) & (Kg)

Table 43. Latin America Alimta Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Alimta Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Alimta Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Alimta Sales by Country (2020-2025) & (Kg)

Table 47. Middle East and Africa Alimta Sales by Country (2026-2031) & (Kg)

Table 48. Middle East and Africa Alimta Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Alimta Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Alimta Sales (Kg) by Type (2020-2025)

Table 51. Global Alimta Sales (Kg) by Type (2026-2031)

Table 52. Global Alimta Sales Market Share by Type (2020-2025)

Table 53. Global Alimta Sales Market Share by Type (2026-2031)

Table 54. Global Alimta Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Alimta Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Alimta Revenue Market Share by Type (2020-2025)

Table 57. Global Alimta Revenue Market Share by Type (2026-2031)

Table 58. Global Alimta Price (USD/g) by Type (2020-2025)

Table 59. Global Alimta Price (USD/g) by Type (2026-2031)

Table 60. Global Alimta Sales (Kg) by Application (2020-2025)

Table 61. Global Alimta Sales (Kg) by Application (2026-2031)

Table 62. Global Alimta Sales Market Share by Application (2020-2025)

Table 63. Global Alimta Sales Market Share by Application (2026-2031)

Table 64. Global Alimta Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Alimta Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Alimta Revenue Market Share by Application (2020-2025)

Table 67. Global Alimta Revenue Market Share by Application (2026-2031)

Table 68. Global Alimta Price (USD/g) by Application (2020-2025)

Table 69. Global Alimta Price (USD/g) by Application (2026-2031)

Table 70. Eli Lilly Company Information

Table 71. Eli Lilly Description and Business Overview

Table 72. Eli Lilly Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 73. Eli Lilly Alimta Product

Table 74. Eli Lilly Recent Developments/Updates

Table 75. Abbott Healthcare Company Information

Table 76. Abbott Healthcare Description and Business Overview

Table 77. Abbott Healthcare Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 78. Abbott Healthcare Alimta Product

Table 79. Abbott Healthcare Recent Developments/Updates

Table 80. Cadila Healthcare Company Information

Table 81. Cadila Healthcare Description and Business Overview

Table 82. Cadila Healthcare Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 83. Cadila Healthcare Alimta Product

Table 84. Cadila Healthcare Recent Developments/Updates

Table 85. Eagle Pharmaceuticals Company Information

Table 86. Eagle Pharmaceuticals Description and Business Overview

Table 87. Eagle Pharmaceuticals Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 88. Eagle Pharmaceuticals Alimta Product

Table 89. Eagle Pharmaceuticals Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Alimta Distributors List

Table 93. Alimta Customers List

Table 94. Alimta Market Trends

Table 95. Alimta Market Drivers

Table 96. Alimta Market Challenges

Table 97. Alimta Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of Alimta

Figure 2. Global Alimta Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Alimta Market Share by Type: 2024 & 2031

Figure 4. 100mg Product Picture

Figure 5. 500mg Product Picture

Figure 6. Global Alimta Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Alimta Market Share by Application: 2024 & 2031

Figure 8. Pleural Mesothelioma

Figure 9. Non-small Cell Lung Cancer

Figure 10. Global Alimta Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Alimta Market Size (2020-2031) & (US$ Million)

Figure 12. Global Alimta Sales (2020-2031) & (Kg)

Figure 13. Global Alimta Average Price (USD/g) & (2020-2031)

Figure 14. Alimta Report Years Considered

Figure 15. Alimta Sales Share by Manufacturers in 2024

Figure 16. Global Alimta Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Alimta Players: Market Share by Revenue in Alimta in 2024

Figure 18. Alimta Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Alimta Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Alimta Sales Market Share by Country (2020-2031)

Figure 21. North America Alimta Revenue Market Share by Country (2020-2031)

Figure 22. U.S. Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Alimta Sales Market Share by Country (2020-2031)

Figure 25. Europe Alimta Revenue Market Share by Country (2020-2031)

Figure 26. Germany Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Alimta Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Alimta Revenue Market Share by Region (2020-2031)

Figure 33. China Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Taiwan Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Philippines Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Alimta Sales Market Share by Country (2020-2031)

Figure 44. Latin America Alimta Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Alimta Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Alimta Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. U.A.E Alimta Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Alimta by Type (2020-2031)

Figure 54. Global Revenue Market Share of Alimta by Type (2020-2031)

Figure 55. Global Alimta Price (USD/g) by Type (2020-2031)

Figure 56. Global Sales Market Share of Alimta by Application (2020-2031)

Figure 57. Global Revenue Market Share of Alimta by Application (2020-2031)

Figure 58. Global Alimta Price (USD/g) by Application (2020-2031)

Figure 59. Alimta Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

Related Reports

Global Alimta Market Research Report 2024
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-01-04
Pages: 74
USD 2900.00
(Single User License)
Alimta - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-01-24
Pages: 85
USD 3950.00
(Single User License)
Global Alimta Market Insights, Forecast to 2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-04-15
Pages: 76
USD 4900.00
(Single User License)
Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Alimta was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 85
USD 3950.00
(Single User License)
Global Alimta Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Alimta market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 71
USD 4250.00
(Single User License)
Global Alimta Market Research Report 2026
The global Alimta market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 97
USD 2900.00
(Single User License)
Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Alimta was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 122
USD 3950.00
(Single User License)

Global Alimta Market Research Report 2024
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-01-04
Pages: 74
USD 2900.00 (Single User License)
Alimta - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-01-24
Pages: 85
USD 3950.00 (Single User License)
Global Alimta Market Insights, Forecast to 2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-04-15
Pages: 76
USD 4900.00 (Single User License)
Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Alimta was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 85
USD 3950.00 (Single User License)
Global Alimta Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Alimta market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 71
USD 4250.00 (Single User License)
Global Alimta Market Research Report 2026
The global Alimta market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 97
USD 2900.00 (Single User License)
Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Alimta was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 122
USD 3950.00 (Single User License)